tiprankstipranks
Urogen Pharma (DE:UR8)
FRANKFURT:UR8
Germany Market

Urogen Pharma (UR8) Blogger Opinions & Sentiment

1 Followers

Blogger Sentiment

Bullish: 80.00%
Sector Average
Bullish
DE:UR8 Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
40% SeekingAlpha
20% GuruFocus
20% Zacks
20% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Is UroGen Pharma Ltd (URGN) Overvalued Despite Q2 Revenue of $72.5 Million? GF Score: 60/100
GuruFocus
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Wall Street analysts think Urogen Pharma (URGN) could surge 27.14%: Read this before placing a bet
Zacks
UroGen Q1 Review: Zusduri Launch Accelerates, With Profitability Anticipated By 2027
SeekingAlpha
UroGen: Expect Rough Patch Before Strong Recovery In 2026
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of DE:UR8?
Seeking Alpha’s Brendan O'Boyle has a Bullish Sentiment.
    What do Motley Fool contributors think of DE:UR8?
    Currently there's no blogger sentiment for DE:UR8.
    What Is DE:UR8’s Blogger Sentiment?
    DE:UR8’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for DE:UR8?
      The most recent blogger prediction for DE:UR8 was made by Zacks Equity Research, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          DFTXDefinium Therapeutics
          CNCCentene
          VERAVera Therapeutics
          SENSSenseonics Holdings